Divis Laboratories is going to spend Rs.300 crore on expanding capacities of its existing plants. Till December last year, the company had already spent Rs.400 crore on the expansion programme.

Divis is having 4 manufacturing facilities, which is involved in manufacturing of leading generic compounds, nutraceutical ingredients and custom synthesis of APIs and intermediaries for global innovator companies.

Kishore Babu, chief financial officer stated, “Kakinada plant (in AP) may take some more time. The state government has to resolve the farmers issue. We will not undertake any work there until the farmers issue is resolved. So we are expanding the capacities of the existing plants.”

Read EquityPandit’s Technical Analysis on Nifty Pharma Outlook  for the Week